ADAR and cancer: Yet, our findings portray a favorable and encouraging landscape of correctable mutations in cancer, pointing to the possibility of future leveraging the unique capabilities of endogenous-ADAR therapy towards clinical cancer risk/prevention and treatment outcomes.